BeiGene, Ltd. (BGNE)
NASDAQ: BGNE · IEX Real-Time Price · USD
134.05
-4.35 (-3.14%)
At close: Apr 16, 2024, 4:00 PM
140.34
+6.29 (4.69%)
After-hours: Apr 16, 2024, 4:05 PM EDT

BeiGene Statistics

Total Valuation

BeiGene has a market cap or net worth of $15.21 billion. The enterprise value is $12.99 billion.

Market Cap 15.21B
Enterprise Value 12.99B

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, before market open.

Earnings Date May 2, 2024
Ex-Dividend Date n/a

Share Statistics

BeiGene has 113.47 million shares outstanding.

Shares Outstanding 113.47M
Owned by Insiders (%) 0.03%
Owned by Institutions (%) 48.10%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.20
Forward PS 0.72
PB Ratio 4.31
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.28
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.26.

Current Ratio 2.32
Quick Ratio 1.96
Debt / Equity 0.26
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 12.16

Financial Efficiency

Return on equity (ROE) is -23.10% and return on invested capital (ROIC) is -27.03%.

Return on Equity (ROE) -23.10%
Return on Assets (ROA) -15.30%
Return on Capital (ROIC) -27.03%
Revenue Per Employee $231,960
Profits Per Employee -$83,180
Employee Count 10,600
Asset Turnover 0.43
Inventory Turnover 1.09

Taxes

In the past 12 months, BeiGene has paid $55.87 million in taxes.

Income Tax 55.87M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -49.43% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been lower than the market average.

Beta (1Y) 0.63
52-Week Price Change -49.43%
50-Day Moving Average 155.78
200-Day Moving Average 178.20
Relative Strength Index (RSI) 29.43
Average Volume (30 Days) 258,843

Short Selling Information

Short Interest 1.73M
Short Previous Month 1.73M
Short % of Shares Out 5.88%
Short % of Float n/a
Short Ratio (days to cover) 7.43

Income Statement

In the last 12 months, BeiGene had revenue of $2.46 billion and -$881.71 million in losses. Loss per share was -$0.65.

Revenue 2.46B
Gross Profit 2.08B
Operating Income -1.21B
Pretax Income -825.84M
Net Income -881.71M
EBITDA -812.17M
EBIT -899.85M
Loss Per Share -$0.65
Full Income Statement

Balance Sheet

The company has $3.19 billion in cash and $930.19 million in debt, giving a net cash position of $2.26 billion or $19.88 per share.

Cash & Cash Equivalents 3.19B
Total Debt 930.19M
Net Cash 2.26B
Net Cash Per Share $19.88
Equity / Book Value 3.54B
Book Value Per Share 31.17
Working Capital 2.39B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.16 billion and capital expenditures -$561.90 million, giving a free cash flow of -$1.72 billion.

Operating Cash Flow -1.16B
Capital Expenditures -561.90M
Free Cash Flow -1.72B
FCF Per Share -$16.48
Full Cash Flow Statement

Margins

Gross margin is 84.55%, with operating and profit margins of -49.12% and -35.86%.

Gross Margin 84.55%
Operating Margin -49.12%
Pretax Margin -33.59%
Profit Margin -35.86%
EBITDA Margin -33.03%
EBIT Margin -36.60%
FCF Margin -69.93%

Dividends & Yields

BeiGene does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.22%
Shareholder Yield -1.22%
Earnings Yield -5.78%
FCF Yield -11.28%
Dividend Details

Analyst Forecast

The average price target for BeiGene is $256.26, which is 91.17% higher than the current price. The consensus rating is "Buy".

Price Target $256.26
Price Target Difference 91.17%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 83.31%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BeiGene has an Altman Z-Score of 2.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.52
Piotroski F-Score 3